Xcorporeal Stock

Xcorporeal ROA

The Return on Assets (ROA) of Xcorporeal (XCRP) as of Aug 8, 2026 is -528.22 %.

ROA

-528.22 %

Last updated:

In 2026, Xcorporeal's return on assets (ROA) was -528.22 %, a % increase from the - ROA in the previous year.

Access this data via the Eulerpool API

Xcorporeal Stock analysis

What does Xcorporeal do? Xcorporeal Inc is an American medical technology company specialized in the development and marketing of innovative medical devices. The company was founded in 2002 and is headquartered in Los Angeles, California. The company operates in the field of extracorporeal therapy, where blood is cleansed outside the body. The goal is to rid the body of toxins and excess fluids when the kidneys or liver are not functioning properly. Xcorporeal Inc's business model is based on the development and marketing of extracorporeal therapy devices. The company aims to lead in the field of renal replacement therapy, blood purification, and soluble sepsis treatment. In this context, Xcorporeal Inc is a pioneer in the field of portable hemodialysis devices, which allow patients to receive continuous kidney function treatment. The devices are designed to be easy to use and provide patients with mobility and quality of life. Xcorporeal Inc offers a variety of products tailored to the needs of patients and medical personnel. The portable hemodialysis device FloWatch is one of Xcorporeal Inc's most well-known products. It allows patients to perform treatment at home, providing them with more flexibility and self-determination. Additionally, Xcorporeal Inc has also developed a solution for the treatment of sepsis. Soluble Sepsis Therapy (SST) is a groundbreaking procedure in which blood is pumped through a special filter technology to remove dangerous toxins and inflammatory substances from the blood. Xcorporeal Inc currently operates two divisions focused on other applications of extracorporeal therapy. The first division focuses on the development of devices for blood purification and fighting infections. The second division is involved in the development of medical instruments for use in research and development. Overall, Xcorporeal Inc has the potential to change the face of extracorporeal therapy. With its innovative products and pioneering spirit in the field of portable hemodialysis devices, the company has shown that it is capable of transforming the market and revolutionizing the way extracorporeal therapy is practiced. Xcorporeal is one of the most popular companies on Eulerpool.

ROA Details

Understanding Xcorporeal's Return on Assets (ROA)

Xcorporeal's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Xcorporeal's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Xcorporeal's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Xcorporeal’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Xcorporeal stock

Return on Assets (ROA) of Xcorporeal is -528.22 % in 2026.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Xcorporeal since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Xcorporeal with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

Profitability — Xcorporeal

All Key Metrics — Xcorporeal